Back to 
BlackRock Finance, Inc.
BlackRock Finance, Inc.
TPST
Showing 0 of 3 quarters
Position history for BlackRock Finance, Inc.'s holdings in Tempest Therapeutics, Inc.
As of its last 13F, for Q2 2024, BlackRock Finance held 550,241 shares of TPST (Tempest Therapeutics), worth $1.2M. It increased the position by 42,046 shares (+8.3%) from Q1 2024. BlackRock Finance held TPST from Q4 2023 to Q2 2024, across 3 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of TPST: FMR LLC